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Abstract Single functional human CuZnSOD gene encodes two 
species of mRNA differing in size by 200 nucleotides in the 3'- 
untranslated region (UTR). We studied the expression of the 
CuZnSOD cDNA with different 3'- and 5'-UTR. Deletion in the 
5'-end does not affect the expression of the enzyme, however, 
deletion in the 3'-UTR decreases the level of expression of 
CuZnSOD. The plasmids containing the long CuZnSOD cDNA 
with all polyadenylation signal sequences utilize primarily the last 
polyadenylation site and give a long mRNA, which produces three 
times more enzyme than the short mRNA lacking the last poly- 
adenylation site and the AU-rich region. 
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1. Introduction 
Important components of a defence system against oxic 
oxygen radicals are superoxide dismutases (SODs) - metalloen- 
zymes, which dismutate superoxide free radicals [1]. Each 
eukaryotic cell has several types of the superoxide disrnutases: 
mitochondrial SOD (MnSOD), a cytosolic SOD (CuZnSOD) 
[2,3], and an extracellular CuZnSOD [4]. 
It has been suggested that SODs are involved in the acute 
inflammatory esponse and in the transformation f cells [5-8]. 
Overproduction f CuZnSOD is believed to be involved in the 
pathology of Down's syndrome [9,10]. Mutations in the 
CuZnSOD gene are associated with familial amyotrophic lat- 
eral sclerosis [11-14]. The regulation mechanism of SOD activ- 
ity has not been fully understood yet. It is known that copper 
takes part in the regulation of CuZnSOD activity at the post- 
translational level [15]. For rat MnSOD five mRNAs have been 
isolated and characterized. They all have been derived from a 
single functional gene, the heterogenity of the MnSOD tran- 
scripts resulting from the length variation of the 3'-noncoding 
sequence [5]. The sequences of MnSOD cDNA of a human 
tumour and normal cells exhibit differences in both the 5'- and 
the 3'-untranslated r gion (UTR), but have no mutations in the 
translated region [8]. Similary to rat MnSOD, a single func- 
tional human CuZnSOD gene gives more than one mRNA: 
poly(A)-containing RNA from various tissues contains two 
species of CuZnSOD mRNA, differing in size by 200 nucleo- 
tides [16]. These mRNAs differ in the lengths of their 3'-UTR 
*Corresponding author. Fax: (372) (7) 420 286. 
Abbreviations: SOD, superoxide dismutase; UTR, untranslated region; 
BES, N,-N-bis(2-hydroxyethyl)-2-aminoethan sulphonic acid; PCR, 
polymerase chain reaction; PAAG, polyacrylamide g l; dssDNA, dena- 
tured salmon sperm DNA. 
and both of them possess multiple 5'-termini. The short mRNA 
(0.7 kb) is polyadenylated at the first polyadenylation site and 
the polyadenylation site of the 0.9 kb SOD mRNA is 249 bp 
downstream [17]. 
de Sauvage t al. [18] have studied the alternative polyadenyl- 
ated amyloid protein precursor mRNA and have demonstrated 
that the long mRNA, which is created through the usage of the 
second polyadenylation site, has an ability to produce more 
protein than the short mRNA. At the same time the long 
mRNA was degraded more rapidly. The sequence between the 
two polyadenylation sites in the 3'-UTR of amyloid protein 
precursor mRNA was also able to increase the production of 
the chicken lysozyme or the chloramphenicol acetyltransferase 
after ligation of this 3'-UTR element to the 3'-end of reporter 
genes. Several works demonstrate hat the 3'-UTR of mRNA 
is involved in the control of the stability of mRNA [19-22]. 
We cloned and sequenced a full-length uman CuZnSOD 
cDNA from the histiocytic lymphoma cell line U937/B. We 
studied the effect of 3'- and 5'-UTR on the expression of these 
cDNAs at the protein level. We demonstrated that compared 
to cells transfected with a cDNA with truncated 3'-UTR, there 
is more enzyme synthesized in cells transfected with a long 
cDNA containing the long 3'-UTR. We did not find any effect 
of the deletion in 5'-UTR on the expression of the enzyme. 
2. Materials and methods 
2.1. Construction of U937/B cDNA expression library 
Total RNA from the histiocytic lymphoma serum-free cell line 
(U937/B) was purified on biotinylated oligo(dT) (Promega). cDNA first 
strand was synthesized from poly(A) ÷ RNA by MoMuLV reverse tran- 
scriptase by using a poly(dT) XhoI linker-primer. The second strand 
was synthesized byDNA polymerase I, protruding ends were filled with 
T4 DNA polymerase, ligated with EcoRI adaptors, phosphorylated at 
the 5'-end with T4 polynucleotide kinase and restricted with XhoI. 
2 ZAP II vector [23] (Stratagene) was restricted with EcoRl/XhoI endo- 
nucleases, ligated, and packaged. The resulting cDNA library con- 
tained about 120,000 clones. 
2.2. Analysis of cDNA clones 
Complementary DNA were isolated from a library constructed from 
mRNA of the histiocytic lymphorna cell ine U937/B. About 105 recom- 
binant phages from the library were screened by using a mutant 
CuZnSOD cDNA, amplified by the method of PCR [24] from a human 
liver cDNA library. The cDNA was labelled by multipriming nick- 
translation (Amersham). From the phage particles of the four hybridiz- 
ing plaques the plasmid Bluescript SK(M13-) was isolated by using a 
helper phage R408 [23]. After the restriction analysis two SOD-positive 
clones were sequenced by using the dideoxynucleotide termination 
method [25]. 
2.3. Plasmids and cloning procedures 
The basic eukaryotic expression vector pCG [26] was used for the 
cloning of cDNAs. Standard recombinant DNA techniques were used 
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in the construction of all plasmids [27]. Briefly, XhoI-EcoRI fragment 
from Bluescript(M 13-) was cloned into the polycloning site of the plas- 
mid pGEM7, from the latter a XbaI-BamHI fragment containing SOD 
eDNA was cloned into pCG. For deletion in the 5'-end restrictase PstI 
was used and for deletion in the 3'-end BclI was used (Fig. 1A). 
2.4. Cells and transfection 
The monkey cell line COS 1 (cells producing constitutively SV40 T 
antigen) and the human cell line 293 were grown in DMEM supple- 
mented with 10% fetal calf serum (FCS) and antibiotics (penicillin 100 
U/ml, streptomycin 0.1 mg/ml) at 37°C in a 10% COz incubator. The 
SOD expression constructs (6 ¢tg) were electroporated into COS 1 cells 
(3-6 x 106) at 180 V and into human 293 cells (i0 x 106) at 160 V in 250 
/11 of DMEM supplemented with 10% FCS, 6 mM BES, 50/lg of 
dssDNA at room temperature [28]. 
2.5. Assays of SOD activity 
48 h after transfection the cells (1-2 x 106) were washed twice with 
PBS, suspended in 100 ¢tl H20 and disrupted by four cycles of freezing 
at -70°C and thawing at +60°C. Lysates were centrifuged for 15 min 
with 14,000 rpm at 4°C (Eppendorf centrifuge). SOD activity was 
measured by a pyrogallol method [29]. The reaction of autooxidation 
of pyrogallol and the inhibition of this reaction by cell extracts was 
spectrophotometrically monitored. 1 unit of SOD activity equals the 
amount of enzyme producing a 50% inhibition in the autooxidation of
pyrogallol. SOD activity is expressed in units per mg of protein.The 
total protein in lysates was determined by Coomassie brilliant blue 
G-250 [30], standardized with bovin serum albumin. 
The lysates were analysed on the 15% PAAG under non-denatu- 
rating conditions and the SOD activity was determined by nitroblue 
tetrazolium [31]. SOD activity appears as a transparent band in the blue 
formazan pigment background. A 15% PAAG can be used to separate 
MnSOD and CuZnSOD. However, our lysates do not contain any 
detectable amounts of MnSOD. As a positive control we used 
CuZnSOD isolated from red blood cells. The cells were lysed for 10 min 
in one volume of distilled water at 75-80°C, quickly cooled at 40°C and 
filtrated. The rest of hemoglobin was precipitated by 0.25 vol. of etha- 
nol and 0.15 vol. of chloroform. 
2.6. RNA analysis 
Cytoplasmic RNA was isolated from cells (1-2 x 10 6) 24 h after 
transfection by standard method [27]. 20/zg of total RNA was sepa- 
rated on 1.2% agarose/formaldehyde gel, RNA was transferred to a 
nylon membrane (Nybond N, Amersham) and covalently crosslinked 
to the membrane with UV light [27]. The membranes were hybridized 
overnight with a radiolabelled human CuZnSOD cDNA probe (XbaI- 
BamHI fragment, Fig. 1A) in 6 x SSC, 5 x Denhardt's reagent, 0.1% 
SDS and 100/lg/ml dssDNA at 68°C, washed 2 x SSC, 0.1% SDS at 
room temperature, 2 × 15 min, and 0.2 × SSC, 0.5% SDS at 68°C 2 h 
(4 × 300 ml) and identified by autoradiography. 
3. Results 
3.1. Construction of  the CuZnSOD expression vectors with 
differences at the 5"- and 3"- UTR of  the cDNA 
One SOD-positive clone from a human histiocytic lymphoma 
cDNA library contained a full-length CuZnSOD cDNA. The 
long 3 ' -UTR (345 nucleotides) and the protein coding sequence 
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Fig. 1. Schematic structure of plasmid containing the CuZnSOD eDNA and its derivates. The arrows indicate the position of the restriction sites 
used for cloning. (A) Plasmid pCGSOD contains a bacterial plasmid sequence (AM), CMV promotor (P), the rabbit genomic sequence for splicing 
and polyadenylation (i, p(A), thick line), SV40 origin fragment (O) and full-length CuZnSOD cDNA as the Xbal BamHI fragment, open box 
represents he coding sequence and the filled box, the untranslated regions. 5'-UTR, nucleotide sequence of the transcription i itiation region of SOD-1 
gene [17] (small type), and 5'-end of the CuZnSOD cDNA in our experiments; 3'-UTR, 3'-region of the CuZnSOD eDNA containing the stop codon 
TAA, the five polyadenylation signal sequences, two cleavage and polyadenylation sites p(A)I, p(A)II, and the GT-rich box G/T [33] (The sequence 
is presented in Fig. 4). (B) Deletions in the 5'- and 3'-UTR of SOD eDNA (A5'-A3"-) and in the vector sequence (AiAp(A)). 
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Fig. 2. Analysis of the CuZnSOD enzymatic activity in COS 1 cells 
transfected with plasmids pCGSODA3'- (A3'-), pCGSODA3'-Ai (A3'-Ai), 
pCGSODA5'-Ai (A5'-Ai), pCGSOD (SOD), pCGSODA5'-A3"-AiAp(A) 
(A5"-A3'-AiAp(A)) or without SOD plasmid (-). (A) Cell extracts (10 pg 
of protein) and erytrocyte CuZnSOD (the first left lane) electrophor- 
esed on a native 15% PAAG and stained for SOD activity. The arrows 
indicate the position of monkey CuZnSOD (mSOD), heterodimer of
human and monkey's subunits of CuZnSOD (h/m SOD) and the human 
CuZnSOD (hSOD). (B) SOD activity (units/mg of cell protein) deter- 
mined by spectrophotometric pyrogallol method. Each post represents 
the average of double plates of the same transfection, with error bars 
included. This experiment was repeated six times with reproducible 
results, the example shown is repesentative. 
are identical to the published one[17,32,33]. The 5'-UTR 
showed an unusual sequence. While the genomic sequence of 
the transcription initiation site is ...GCTG GTTTGCG... 
[17,32], our cDNA has 14 T instead of 3 T: ...G(T)14GCG... 
(Fig. 1A). Another difference is that at position 20 there is a 
C between two Gs (Fig. 1A). This C is absent in some published 
genomic sequences [17,32], but it is present in sequence pub- 
lished by Hallewell [33]. The CuZnSOD full-length cDNA, con- 
taining in its T-end 15 A nucleotide in addition to the genomic 
sequence, was cloned into the vector pCG as a XbaI-BamHI 
fragment (Fig. 1A, plasmid pCGSOD). The plasmid 
pCGSODA5'-Ai contains neither the oligo(dT)~4 and 18 first 
nucleotides atthe 5'-end of SOD cDNA up to PstI site nor the 
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rabbit fl-globin intron sequence of the vector pCG up to BglII 
site (Fig. 1B). The plasmid pCGSODA3' lacks the last 185 
nucleotides, i.e. the last polyadenylation site of SOD cDNA up 
to BclI site, and it contains only the two first polyadenylation 
signal sequences and G/T box downsrteam p(A)I (Fig. 1A). The 
plasmid pCGSODA3'-Ai s identical to pCGSODA3'- with the 
exeption of lacking the fl-globin intron sequence of the vector 
pCG up to BglII site (Fig. 1B). The plasmid pCGSODA5'-A3'- 
AiAp(A) differs from the others in that it lacks all the rabbit 
genomic sequence of the vector pCG, the 5'-end and the 3'-end 
of the SOD cDNA up to PstI and BclI sites, respectively (Fig. 
1B). mRNAs from the plasmids the pCGSODA3'-, 
pCGSODA3'-Ai and pCGSODA5"-A3'-AiAp(A) can be polyad- 
enylated at the first polyadenylation site p(A)I of SOD cDNA 
(Fig. 1A). The plasmids pCGSOD and pCGSODA5'-Ai have 
the possibility to utilize all polyadenylation sites in CuZnSOD 
cDNA 3'-UTR (Fig. 1). 
3.2. Expression of the human CuZnSOD cDNAs transfected in
monkey cell line COS 1 and in human cell line 293 
The plasmids containing CuZnSOD cDNA or its derivates 
were transfected into the monkey cell line COS 1 and into the 
human cell line 293 by electroporation [28]. In transient exper- 
iments 48 h after the transfection cells were harvested and lysed. 
In the lysates the SOD activity was measured by two different 
methods. (Fig. 2) After the separation of proteins on the 15% 
PAAG under non-denaturating conditions, the SOD activity 
was made manifest by the nitroblue tetrazolium ethod [31]. 
All SOD cDNA-containing plasmids transfected into COS 1 
cells express the human CuZnSOD activity at high level (Fig. 
2A). In a control experiment only the carrier DNA was trans- 
fected, and only the monkey's own CuZnSOD (mSOD, Fig. 
2A, lane - )  is expressed there. CuZnSOD is a dimer composed 
of two identical subunits. Therefore, the active nzyme can also 
form a heterodimer of monkey's and human subunits, which 
can be seen in Fig. 2A as the middle band in the extracts of the 
cell transfected with SOD plasmids. A quantitative evaluation 
A52X3' 
cDNA A3Ai A5Ai SOD AiAp(A) 
28S 
18S 
1 2 3 4 5 
28S 
18S ---~ 
Fig. 3. Northern blot analysis of human CuZnSOD mRNAs. 20 ¢tg of 
total cytoplasmic RNA of COS 1 cells transfected with the plasmid 
pCGSODA3'-Ai (lane 1), pCGSODA5'-Ai (lane 2), pCGSOD (lane 3), 
pCGSODA5"-A3"-AiAp(A) (lane 4) or without SOD cDNA (lane 5) elec- 
trophoresed on a 1.2% agarose/formaldehyde gel. Hybridization was 
performed with 32p-labelled human CuZnSOD cDNA. The position of 
the 18 S and 28 S ribosomal RNA are shown to the left and amounts 
of RNA are shown on the bottom panel, on the picture of the ethidium 
bromide-stained agarose gel. 
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ACATTCCCTTGGATGTAGTCTGAGGCCCCTTAACTCATCTGTTATC 
CTGCTAGCTGTAGAAATGTATCCTGATAAACATTAAACACTGTAAT 
CTTAAAASGTGTAATTGTGTGACTTTTTCAGAGTTGCTTTAAAGTA 
CCTGTAGTGAGAAACTGATTTAT 
SGATCACTTGGAAGATTTGTATAGTTTTATAAAACTCAGTTAAAA 
TGTCTGTTTCAATGACCTGTATTTTGCCAGACTTAAATCACAGATG 
GGTATTAAACTTGTCAGAATIq'CTTTGTCATTCAAGCCTGTGAATA 
AAAACCCTGTATGGCACTTATTATGAGGCTATTAAAAGAATCCAA 
ATTCAAASaaaaa~n~aaaaaactgg~actagttct~gccg~cc 
ATAAATAAATTAAATAAAATAA,I-CCCCGGGCAAGACTTTTCTTTGA 
AGGATGACTACAGACATTAAATAATCGAAGTAATTTTGGGTGGGG 
AGAAGAGGCAGATTCAATTTTCTTI?AACCAGTCTGAAGTTTCATT 
TATGATACAAAAGAAGATGAAAATGGAAGTGGCAATATAAGGGG 
ATGAGGAAGGCATGCCTGGACAAACCCTTCT'ITrAAGATGTGTCT 
TCAATTTGTATAAAATGGTGTTTTCATGTAAATAAATACATTCTTG 
GAGGAGC~- 
Fig. 4. Nucleotide sequence of the 3'-UTR of the CuZnSOD cDNA (A) 
[17] and of the amyloid protein precursor cDNA (B) [18]. The AU 
motifs are in heavy type, the polyadenylation sites are designated by the 
arrows, the disruption with an arrow indicates the site of the deletion 
of the last 185 nucleotide of the 3"-UTR of the CuZnSOD cDNA, and 
the short Y-UTR of the SOD mRNA is underlined.The s quence after 
the last polyadenylation site of CuZnSOD cDNA in our constructs i  
designated by small type. 
was made by a spectrophotometric pyrogallol method (Fig. 
2B). The CuZnSOD cDNA lacking the last polyadenylation 
signal sequences at the Y-end shows lower enzymatic activity. 
While comparing the exogeneous SOD activities, i.e. the con- 
trol level count off, it appears that all plasmids containing 
A3'-cDNA produce three times less enzyme than full-length 
cDNA (Table 1). Deletion in the Y-end of SOD cDNA has no 
significant effect on the expression (Fig. 2). The plasmids 
pCGSODA3'-, pCGSODA3'-Ai and pCGSODA5"-A3"-AiAp(A) 
give the expression early at the same level (Fig. 2). The rabbit 
genomic sequence for splicing and polyadenylation in the pCG 
vector does not affect the expression of the SOD cDNA. 
The expression of the SV40 T antigen in COS cells allows 
replication of pCG plasmids to a high copy number, which 
results in high levels of transcription and enzyme activity. In 
the human cell line 293 the plasmid pCG does not have a high 
copy number and the levels of enzyme activity are lower. But 
like in COS, in cells of the human cell line 293 the expression 
of full-length or A5'-SOD gives three times higher enzyme activ- 
ity than plasmids containing the short cDNA (Table 1). 
3.3. Analysis of CuZnSOD mRNA in cells transfected 
CuZnSOD cDNAs 
In our experiments 24 h after transfection pCGSOD plas- 
mids into the COS 1 cells cytoplasmic RNA was isolated and 
analysed. The results are presented in Figure 3. In the cells COS 
1, not transfected with the human CuZnSOD cDNA, no 
CuZnSOD mRNA could be detected by using a human-specific 
probe (Fig. 3, lane 5). The CuZnSOD cDNAs lacking the last 
polyadenylation signal sequences at the 3'-end allow the synthe- 
sis of the short mRNA only (Fig. 3, lane 1 and 4). Concerning 
the transcription of the plasmids pCGSOD and pCGSODA5'- 
Ai, containing all polyadenylation sites and in addition 15 A 
nucleotide in its 3'-end, the last polyadenylation site p(A)II was 
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preferred. We can primarily see the long mRNA (Fig. 3, lane 
2 and 3). 
4. Discussion 
We studied the effect of 3'- and 5'-UTR on the expression 
of the CuZnSOD cDNA and observed that, the deletion of the 
last 185 nucleotides from the 3'-UTR reduces the level of en- 
zyme activity by three times. This deleted fragment contains the 
last three polyadenylation signal sequences of CuZnSOD 
cDNA. In human cells normally two CuZnSOD mRNAs of 0.9 
and 0.7 kb have been detected [16,17]. For polyadenylation f 
these mRNAs different polyadenylation sites are used. The 
short mRNA is polyadenylated at the first polyadenylation site 
p(A)I and long one at p(A)II (Fig. 1) [17]. Plasmids pCGSOD 
and pCGSODA5'-Ai contain all polyadenylation sites of 
CuZnSOD mRNA and in addition a (A)js-tail (Fig. 4). They 
allow the production of short and long mRNA. When these 
plasmids were expressed in the monkey cell line COS 1, mostly 
the long mRNA was synthesized (Fig. 3). While from the en- 
dogenous human CuZnSOD gene shorter mRNA is tran- 
scribed four times more efficiently than the longer mRNA [17]. 
The mechanism, which regulates the ratio between two mRNA 
species, is unknown. It seems that the ratio is not only regulated 
by 3'-UTR of cDNA. Evidently others genomic sequences are 
involved in the splicing of CuZnSOD pre-mRNA. When the 
long CuZnSOD cDNA containing an oligo(A) in its Y-end was 
cloned into the plasmid, the mechanism of the regulation might 
have been different han that of the chromosomal CuZnSOD 
gene. Expression of the plasmid giving the long mRNA, pro- 
duced three times more SOD enzyme than the plasmid with the 
truncated Y-UTR of CuZnSOD cDNA (Fig. 2). 
An alternative polyadenylation has been shown for some 
mRNAs: MnSOD mRNA [5], amyloid protein precursor 
mRNA [18], human PR264/SC35 splicing factor mRNA [21], 
Xenopus ~-tubulin mRNA [34]. Y-UTR can control gene ex- 
pression through different mechanisms [35-37]. 3'-UTR deter- 
mines the stability of mRNA in some cases [20-22]. Savant- 
Bhonsale and Cleveland [20] have shown that granulocyte mon- 
ocyte colony stimulating factor mRNA contains in its 3'-UTR 
five AU-rich domains and this region mediates the extreme 
instability of the mRNA. The most important are AUUUA 
motifs. For the instability of the mRNA an active translation 
of this mRNA is required in addition to the AU-rich region in 
the 3'-UTR. They have proposed that the RNA instability 
mediated by the AU-motif is achieved through a translation- 
dependent assembly of a large mRNA-destabilizing complex. 
Table 1 
Expression of the human CuZnSOD cDNA in monkey cell line COS 
1 and in human cell line 293 
Transfected plasmid CuZnSOD activity* 
(u/mg of cell protein) 
COS cells 293 cells 
pCGSODAY 17 + 2 2.6 + 0.3 
pCGSODA3"Ai 18 + 2 2.4 + 0.3 
pCGSODA5'Ai 45 + 4 7.9 + 0.5 
pCGSOD 52 + 4 7.5 + 0.5 
pCGSODA5'AYAiAp(A) 12 + 2 2.4 + 0.2 
*CuZnSOD activity - difference of SOD activity between SOD plasmid 
transfected cells and control cells. 
A. Kilk et al./FEBS Letters 362 (1995) 323-327 327 
Sauvage t al. [18] have shown that the alternative polyadenyl- 
ation regulates translation: two amyloid protein precursor 
mRNA,  differing from Y-UTR, are translated in Xenopus 
oocytes. It was demonstrated that the long mRNA using the 
second polyadenylation site produces more protein than the 
short one. However, the long mRNA is degraded more rapidly. 
The long 3'-UTR of the amyloid protein precursor mRNA 
contains the AU-rich region, within it one AUUUA motif (Fig. 
4), supposedly mediating the translation-dependent instability 
of mRNA [20]. 
We have shown that the plasmid containing a long 
CuZnSOD cDNA produces more SOD activity than the plas- 
mid with a short cDNA of this gene. In between the first 
polyadenylation site and the last polyadenylation site of 
CuZnSOD mRNA contains an AU-rich region, within it one 
AUUUA motif  and five incomplete motifs CUUUA,  
AUUUG,  GUUUUA,  AUUUU,  AUUUC (Fig. 4). There are 
no such kind of motifs in the region upstream the first polyad- 
enylation site (Fig. 4). Since the long CuZnSOD mRNA,  like 
amyloid protein precursor mRNA,  contains the AUUUA mo- 
tifs (Fig. 4), we can speculate that the ability of the mRNA to 
produce more CuZnSOD enzyme may be depend on this se- 
quence in 3'-UTR. In the further experiments we plan the 
identification of the sequences in the 3'-UTR, which are respon- 
sible for enhanced production of the enzyme. The processing 
of the mRNA of CuZnSOD might be an additional regulatory 
mechanism for the expression of this important defence en- 
zyme. The post-transcriptional control of the CuZnSOD allows 
for a fast cellular response in the enzyme level. 
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